← BWX overview

BWX vs Centrus Energy: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

BWX Technologies Inc (BWXT)

Q3 2026
▲4

BWXT Q3: Guidance Raised, Backlog Surges, New Nuclear Deals

  • Guidance raised after strong Q2 results BWXT raised its full-year guidance after Q2 revenue rose 18% to $901.6 million and earnings per share beat estimates. This shows the company is performing better than expected and expects continued strength.

    Guidance raise and earnings beat are key new positive developments that directly affect investor expectations.

  • Backlog jumps 39.6% to $8.4 billion BWXT's backlog surged 39.6% to $8.4 billion, indicating strong future revenue visibility. This growth reflects robust demand across its nuclear defense and commercial businesses.

    Backlog growth is a critical indicator of future revenue and was not mentioned in earlier reports.

  • New contracts: Army microreactor and Canadian nuclear plant BWXT won a U.S. Army contract for the Janus microreactor and a deal for a Canadian transportable nuclear plant. These expand its footprint in mobile and small nuclear power.

    These are new contract wins that open additional revenue streams and demonstrate BWXT's technological leadership.

  • First investment-grade rating and strategic portfolio moves BWXT secured its first investment-grade credit rating (BBB) and sold its medical unit for $800 million, sharpening focus on core nuclear operations. The Saudi 30-year nuclear pact also boosts long-term prospects.

    These strategic actions improve financial flexibility and focus, supporting growth and shareholder value.

September 2026
▲4

BWXT Wins New Reactor Deals, Expands Capacity, Targets $6B Revenue by 2030

  • U.S. Army Janus Program Selection BWXT was chosen to deploy its BANR microreactor for the U.S. Army's Janus program, with the first unit planned at Fort Campbell. This is a major government contract that adds long-term revenue and validates BWXT's advanced reactor technology, pushing the stock up.

    This is a new, significant contract win that directly boosts future demand and revenue visibility.

  • Manufacturing Expansion and Strong 2025 Revenue BWXT expanded its Cambridge, Ontario facility and is investing in uranium processing and advanced manufacturing. Its 2025 revenue rose 18.3% to $3.2 billion, with projected EPS growth ahead. This shows execution and capacity to meet rising nuclear demand, supporting the stock.

    It highlights tangible growth and investment that underpin future earnings.

  • Inaugural Investment Grade Credit Rating Fitch gave BWXT its first investment grade rating of BBB with a stable outlook, citing its strong market position and cash flow. This lowers borrowing costs and signals financial health, which can attract more investors and lift the stock.

    A new credit rating improves BWXT's financial profile and investor appeal.

  • Investor Day Targets and Canadian Microreactor Deal BWXT set 2030 revenue targets of $5.5–$6 billion, doubled its backlog to $8.4 billion, and is selling a non-core unit to fund nuclear growth. It also won a Canadian transportable nuclear plant project. These moves clarify long-term growth and add new demand, supporting the stock despite a recent pullback.

    These are new strategic updates that directly address future growth and market opportunities.

Latest
▲4

BWXT Wins New Reactor Deals, Expands Capacity, Targets $6B Revenue by 2030

  • U.S. Army Janus Program Selection BWXT was chosen to deploy its BANR microreactor for the U.S. Army's Janus program, with the first unit planned at Fort Campbell. This is a major government contract that adds long-term revenue and validates BWXT's advanced reactor technology, pushing the stock up.

    This is a new, significant contract win that directly boosts future demand and revenue visibility.

  • Manufacturing Expansion and Strong 2025 Revenue BWXT expanded its Cambridge, Ontario facility and is investing in uranium processing and advanced manufacturing. Its 2025 revenue rose 18.3% to $3.2 billion, with projected EPS growth ahead. This shows execution and capacity to meet rising nuclear demand, supporting the stock.

    It highlights tangible growth and investment that underpin future earnings.

  • Inaugural Investment Grade Credit Rating Fitch gave BWXT its first investment grade rating of BBB with a stable outlook, citing its strong market position and cash flow. This lowers borrowing costs and signals financial health, which can attract more investors and lift the stock.

    A new credit rating improves BWXT's financial profile and investor appeal.

  • Investor Day Targets and Canadian Microreactor Deal BWXT set 2030 revenue targets of $5.5–$6 billion, doubled its backlog to $8.4 billion, and is selling a non-core unit to fund nuclear growth. It also won a Canadian transportable nuclear plant project. These moves clarify long-term growth and add new demand, supporting the stock despite a recent pullback.

    These are new strategic updates that directly address future growth and market opportunities.

August 2026
▲4

BWXT Raises Guidance on Strong Q2 and Saudi Nuclear Deal

  • Saudi Nuclear Pact Opens New Market The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that favors American companies. BWXT, as a nuclear component and service provider, could win new contracts, boosting future revenue and profit.

    This is a new, major demand driver that expands BWXT's addressable market.

  • Strong Q2 and Raised 2026 Guidance BWXT reported Q2 revenue of $901.6M (up 18%) and EPS of $1.07, beating estimates. It raised full-year EBITDA and EPS guidance, signaling confidence in continued growth.

    This is the core financial update that directly lifts investor expectations and the stock price.

  • Medical Business Sale Sharpens Focus BWXT agreed to sell its medical unit for up to $800M, keeping a minority stake. The proceeds will fund core nuclear defense and commercial power, improving capital allocation and profitability.

    This strategic move frees up capital and refocuses the company on higher-growth areas.

  • Backlog Surges 39.6% to $8.4B BWXT's backlog jumped to $8.40 billion, up 39.6% from last year, driven by strong government and commercial nuclear demand. This provides revenue visibility and supports future growth.

    A record backlog is a key indicator of future sales and earnings power.

▲4

BWXT Raises Guidance on Strong Q2 and Saudi Nuclear Deal

  • Saudi Nuclear Pact Opens New Market The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that favors American companies. BWXT, as a nuclear component and service provider, could win new contracts, boosting future revenue and profit.

    This is a new, major demand driver that expands BWXT's addressable market.

  • Strong Q2 and Raised 2026 Guidance BWXT reported Q2 revenue of $901.6M (up 18%) and EPS of $1.07, beating estimates. It raised full-year EBITDA and EPS guidance, signaling confidence in continued growth.

    This is the core financial update that directly lifts investor expectations and the stock price.

  • Medical Business Sale Sharpens Focus BWXT agreed to sell its medical unit for up to $800M, keeping a minority stake. The proceeds will fund core nuclear defense and commercial power, improving capital allocation and profitability.

    This strategic move frees up capital and refocuses the company on higher-growth areas.

  • Backlog Surges 39.6% to $8.4B BWXT's backlog jumped to $8.40 billion, up 39.6% from last year, driven by strong government and commercial nuclear demand. This provides revenue visibility and supports future growth.

    A record backlog is a key indicator of future sales and earnings power.

Q2 2026
▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

  • mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.

    New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.

  • Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.

    Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.

  • Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.

    New analyst actions reflect improving sentiment and can influence short-term demand for the stock.

  • Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.

    New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

June 2026
▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

  • mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.

    New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.

  • Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.

    Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.

  • Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.

    New analyst actions reflect improving sentiment and can influence short-term demand for the stock.

  • Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.

    New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

▲4

BWXT's nuclear growth accelerates on AI power demand and commercial expansion

  • mPower SMR licensing deal BWXT licensed its mPower small modular reactor technology to Applied Atomics, keeping exclusive manufacturing rights and royalties. This opens a new revenue stream from future SMR deployments, driven by rising electricity demand from data centers.

    New licensing agreement directly adds a potential high-margin revenue stream and validates BWXT's technology.

  • Commercial revenue surges 121% BWXT's commercial nuclear segment revenue jumped 121% in Q1 2026 to $283.6 million, with backlog at $1.72 billion. This shows strong demand for its commercial nuclear components and services, boosting growth prospects.

    Concrete financial data reveals a major growth driver that is new and directly impacts future earnings.

  • Analyst upgrades and price target hikes Seaport Research and Deutsche Bank upgraded BWXT to Buy with price targets of $245 and $255, citing strong results, higher guidance, and the Precision Components acquisition. Upgrades can attract more investors and lift the stock price.

    New analyst actions reflect improving sentiment and can influence short-term demand for the stock.

  • Long-term material supply agreement with ATI BWXT signed a supply deal with ATI through fiscal 2030 for specialized materials used in naval nuclear propulsion. This secures critical inputs for its Navy programs, reducing supply risk and supporting steady production.

    New agreement ensures supply chain stability for a key revenue segment, which is important for long-term growth.

Centrus Energy Corp. (LEU)

Q3 2026
▲3▼1

Centrus expands HALEU lead but dilution and cash burn weigh

  • Q2 earnings beat and backlog growth Centrus beat Q2 expectations with revenue up 14% to $176.1 million and backlog rising to $4.5 billion, showing strong demand for its nuclear fuel services and long-term contracts.

    This is a new positive financial update that directly supports the stock's fundamental story.

  • New HALEU supply deals and DOE award Centrus won a $900 million DOE HALEU award and signed new supply deals with X-Energy, Antares, and Oklo, plus a Korean utility agreement, expanding its customer base and reinforcing its unique position.

    These are new contracts and awards that validate Centrus's technology and growth prospects.

  • U.S.-Saudi nuclear pact and military contract potential A U.S.-Saudi nuclear cooperation pact could open new demand for Centrus's fuel, and a potential U.S. military contract adds another possible revenue stream, boosting investor optimism.

    These are new geopolitical and customer developments that could drive future growth.

  • Dilution and cash burn pressure stock A $500 million stock and warrant offering diluted shareholders and dropped the stock 8.6%, while operating cash flow swung to a $16.7 million outflow and capital spending jumped to $94.8 million, raising concerns about funding needs.

    This is a new negative factor that directly pressured the stock price during the quarter.

September 2026
▲2▼2

Centrus Raises $500M, Adds HALEU Deals, but Cash Burn Jumps

  • $500M stock and warrant offering dilutes shareholders Centrus priced a $500 million offering of stock and warrants, which increases the number of shares and can lower the value of existing ones. The stock fell 8.6% on the news. This is a real drag on the share price, even though the cash can fund growth.

    This is the largest and most immediate price-moving event in the period, directly affecting LEU through dilution.

  • New HALEU supply deals with Antares and Oklo signal real demand Centrus signed a multi-year HALEU supply contract with Antares, including prepayments, and Oklo named Centrus as a HALEU supplier. These binding orders show demand is growing and support Centrus' expansion to commercial-scale production, though deliveries are years away.

    These deals are new and directly tied to Centrus' core business, showing future revenue potential that can lift the stock.

  • WSJ column and Korean utility deal boost confidence A Wall Street Journal column called Centrus a safer nuclear bet deserving an energy security premium, and Korea Hydro & Nuclear Power signed a long-term supply agreement. The stock jumped 7% on the column. This adds credibility and new demand, helping the share price.

    This is a new positive catalyst that directly moved the stock and highlights Centrus' unique position.

  • Cash burn and soaring capital spending raise financial risk Centrus reported a $16.7 million operating cash outflow in the first half of 2026, versus an $89.3 million inflow a year earlier, while capital spending jumped to $94.8 million from $5.7 million. Heavy spending can pressure the stock if it does not lead to timely revenue.

    This is new financial data showing a real counterweight to the growth story, affecting investor confidence.

Latest
▲2▼2

Centrus Raises $500M, Adds HALEU Deals, but Cash Burn Jumps

  • $500M stock and warrant offering dilutes shareholders Centrus priced a $500 million offering of stock and warrants, which increases the number of shares and can lower the value of existing ones. The stock fell 8.6% on the news. This is a real drag on the share price, even though the cash can fund growth.

    This is the largest and most immediate price-moving event in the period, directly affecting LEU through dilution.

  • New HALEU supply deals with Antares and Oklo signal real demand Centrus signed a multi-year HALEU supply contract with Antares, including prepayments, and Oklo named Centrus as a HALEU supplier. These binding orders show demand is growing and support Centrus' expansion to commercial-scale production, though deliveries are years away.

    These deals are new and directly tied to Centrus' core business, showing future revenue potential that can lift the stock.

  • WSJ column and Korean utility deal boost confidence A Wall Street Journal column called Centrus a safer nuclear bet deserving an energy security premium, and Korea Hydro & Nuclear Power signed a long-term supply agreement. The stock jumped 7% on the column. This adds credibility and new demand, helping the share price.

    This is a new positive catalyst that directly moved the stock and highlights Centrus' unique position.

  • Cash burn and soaring capital spending raise financial risk Centrus reported a $16.7 million operating cash outflow in the first half of 2026, versus an $89.3 million inflow a year earlier, while capital spending jumped to $94.8 million from $5.7 million. Heavy spending can pressure the stock if it does not lead to timely revenue.

    This is new financial data showing a real counterweight to the growth story, affecting investor confidence.

August 2026
▲4

Centrus Expands HALEU Lead with Earnings Beat and New Military Market

  • U.S.-Saudi Nuclear Pact Opens New Demand The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that gives American companies a central role and could allow uranium enrichment on Saudi soil. Centrus, as a U.S. fuel supplier, is positioned to benefit from this new demand.

    This is a new geopolitical event that expands the market for Centrus's core products.

  • Q2 Earnings Beat and Backlog Grows to $4.5B Centrus reported Q2 revenue up 14% to $176.1 million, beating estimates, with backlog rising to $4.5 billion. The company also signed a $900 million DOE HALEU award and selected a construction contractor for expansion, though cash used in operations and higher capex are watch items.

    This is a new earnings report that confirms financial strength and growing demand.

  • X-Energy Secures $1B More, Signs Centrus Deal X-Energy will receive up to $1 billion more in DOE funding and has signed long-term enrichment agreements with Centrus. This locks in a key customer for Centrus's HALEU output, supporting future revenue.

    This is a new customer commitment that directly boosts Centrus's order book.

  • CEO Eyes U.S. Military as New Market Centrus CEO said a U.S. government contract to supply enriched uranium for defense could be finalized this year, opening a new market for Navy fuel and tritium. This would add a stable, high-value revenue stream.

    This is a new potential market that could significantly expand Centrus's customer base.

▲4

Centrus Expands HALEU Lead with Earnings Beat and New Military Market

  • U.S.-Saudi Nuclear Pact Opens New Demand The U.S. and Saudi Arabia signed a 30-year civilian nuclear deal that gives American companies a central role and could allow uranium enrichment on Saudi soil. Centrus, as a U.S. fuel supplier, is positioned to benefit from this new demand.

    This is a new geopolitical event that expands the market for Centrus's core products.

  • Q2 Earnings Beat and Backlog Grows to $4.5B Centrus reported Q2 revenue up 14% to $176.1 million, beating estimates, with backlog rising to $4.5 billion. The company also signed a $900 million DOE HALEU award and selected a construction contractor for expansion, though cash used in operations and higher capex are watch items.

    This is a new earnings report that confirms financial strength and growing demand.

  • X-Energy Secures $1B More, Signs Centrus Deal X-Energy will receive up to $1 billion more in DOE funding and has signed long-term enrichment agreements with Centrus. This locks in a key customer for Centrus's HALEU output, supporting future revenue.

    This is a new customer commitment that directly boosts Centrus's order book.

  • CEO Eyes U.S. Military as New Market Centrus CEO said a U.S. government contract to supply enriched uranium for defense could be finalized this year, opening a new market for Navy fuel and tritium. This would add a stable, high-value revenue stream.

    This is a new potential market that could significantly expand Centrus's customer base.

Q2 2026
▲3

Centrus Gains Oklo Fuel Deal, $3.9B Backlog, S&P 600 Entry

  • Oklo HALEU supply deal Centrus signed a multi-year deal to supply HALEU fuel to Oklo's planned Ohio reactors, starting 2029. This locks in a major customer for its American Centrifuge Plant, boosting future revenue and confirming demand for its unique fuel product.

    This is the key new contract that directly drives LEU's growth story and stock reaction.

  • Backlog swells to $3.9 billion Centrus's order backlog reached $3.9 billion, with contracts through 2040, giving long-term cash flow visibility. As the only Western HALEU enricher, it benefits from a market projected to hit $8 billion annually by 2035.

    Shows strong demand and financial visibility that underpin LEU's valuation.

  • S&P SmallCap 600 inclusion Centrus will join the S&P SmallCap 600 index on July 14, 2026. This typically forces index funds to buy the stock, increasing demand and visibility, which can lift the share price in the near term.

    A new event that directly affects stock demand and liquidity.

  • Stock volatility and sector headwinds Centrus shares fell 32% from an all-time high despite strong fundamentals, partly due to a broad sell-off in small modular reactor stocks after a DOE loan program favored large reactors. This shows sentiment can diverge from company-specific progress.

    Provides a counterweight: even with positive news, external factors can pressure the stock.

June 2026
▲3

Centrus Gains Oklo Fuel Deal, $3.9B Backlog, S&P 600 Entry

  • Oklo HALEU supply deal Centrus signed a multi-year deal to supply HALEU fuel to Oklo's planned Ohio reactors, starting 2029. This locks in a major customer for its American Centrifuge Plant, boosting future revenue and confirming demand for its unique fuel product.

    This is the key new contract that directly drives LEU's growth story and stock reaction.

  • Backlog swells to $3.9 billion Centrus's order backlog reached $3.9 billion, with contracts through 2040, giving long-term cash flow visibility. As the only Western HALEU enricher, it benefits from a market projected to hit $8 billion annually by 2035.

    Shows strong demand and financial visibility that underpin LEU's valuation.

  • S&P SmallCap 600 inclusion Centrus will join the S&P SmallCap 600 index on July 14, 2026. This typically forces index funds to buy the stock, increasing demand and visibility, which can lift the share price in the near term.

    A new event that directly affects stock demand and liquidity.

  • Stock volatility and sector headwinds Centrus shares fell 32% from an all-time high despite strong fundamentals, partly due to a broad sell-off in small modular reactor stocks after a DOE loan program favored large reactors. This shows sentiment can diverge from company-specific progress.

    Provides a counterweight: even with positive news, external factors can pressure the stock.

▲3

Centrus Gains Oklo Fuel Deal, $3.9B Backlog, S&P 600 Entry

  • Oklo HALEU supply deal Centrus signed a multi-year deal to supply HALEU fuel to Oklo's planned Ohio reactors, starting 2029. This locks in a major customer for its American Centrifuge Plant, boosting future revenue and confirming demand for its unique fuel product.

    This is the key new contract that directly drives LEU's growth story and stock reaction.

  • Backlog swells to $3.9 billion Centrus's order backlog reached $3.9 billion, with contracts through 2040, giving long-term cash flow visibility. As the only Western HALEU enricher, it benefits from a market projected to hit $8 billion annually by 2035.

    Shows strong demand and financial visibility that underpin LEU's valuation.

  • S&P SmallCap 600 inclusion Centrus will join the S&P SmallCap 600 index on July 14, 2026. This typically forces index funds to buy the stock, increasing demand and visibility, which can lift the share price in the near term.

    A new event that directly affects stock demand and liquidity.

  • Stock volatility and sector headwinds Centrus shares fell 32% from an all-time high despite strong fundamentals, partly due to a broad sell-off in small modular reactor stocks after a DOE loan program favored large reactors. This shows sentiment can diverge from company-specific progress.

    Provides a counterweight: even with positive news, external factors can pressure the stock.